• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC PUERTO RICO OPERATIONS CO. INTERSTIM X; STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCON

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC PUERTO RICO OPERATIONS CO. INTERSTIM X; STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCON Back to Search Results
Model Number 97800
Device Problems Pocket Stimulation (1463); Insufficient Information (3190)
Patient Problems Incontinence (1928); Itching Sensation (1943); Discomfort (2330); Dysuria (2684)
Event Date 11/15/2023
Event Type  malfunction  
Manufacturer Narrative
B3: date is approximate.Month and year are confirmed valid.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Information was received from a patient who was implanted with an implantable neurostimulator (ins) for urinary dysfunction/sacral nerve stim.It was reported that their device is not working.They get up and it pours out of them again.Patient stated they think they may have been turning therapy off previously.Patient said they had just increased stimulation and were feeling it where their ins was.Patient service specialist reviewed general theory and use of external devices.Patient was able to successfully connect to implant and decrease stimulation to a comfortable level.Patient will maintain stimulation level and will continue to track symptoms.Redirect to doctor if issue persists.
 
Event Description
Additional information was received from the patient.They reported that they were sore in their vagina and butt and it was itchy.Patient wanted to walk through how to use external equipment.Walked patient through connecting to ins, patient had stimulation at 0.1.Patient decided to increase stimulation to a comfortable level.Patient stated they felt stimulation in between their legs instead of ins location as previously noted.Patient stated it also hurts to go to the bathroom.Therapy adjustment options reviewed.Patient was directed to follow up with hcp regarding symptoms.Patient stated they have an appointment with hcp on (b)(6).
 
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information was received from the patient.They repeated previously reported therapy issues.Patient said device is not working and has tried all seven of the programs.Patient said maybe helped a little for a short period of time however is back to wearing depends at night and when stands, urine just pours right out and has no control.Patient said that the trial was wonderful.When asked patient stated hasn't had any falls, trauma, or heavy lifting.Patient said that sometimes has increased the setting to the point of discomfort hoping then will experience some improvement in symptom control.During call patient did decrease setting so that stimulation sensation is comfortable.Patient also mentioned that at times only feels stimulation at ins site.Patient said they have discussed results with their healthcare provider (hcp) and was told to continue trying the different programs and redirected to call medtronic.Patient said their hcp mentioned adding medication however patient said they don't want to be on medication.Patient said was on medication before implant but didn't take any medication during the trial and afterwards.Reviewed therapy information and general programming guidance.When asked, patient hasn't been tracking adjustments.Patient will start working one program at a time, noting setting, where feels stimulation sensation and results.Patient was redirected to schedule appointment with hcp if they don't notice at least 50% improvement on any of the standard programs, to request diagnostic testing be performed and also adding custom programs.
 
Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INTERSTIM X
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCON
Manufacturer (Section D)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
Manufacturer (Section G)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
Manufacturer Contact
glen belmer
7000 central avenue ne rcw215
minneapolis, MN 55432
6122713209
MDR Report Key18290023
MDR Text Key330001938
Report Number3004209178-2023-25399
Device Sequence Number1
Product Code EZW
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P970004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date 05/01/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number97800
Device Catalogue Number97800
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 11/23/2023
Initial Date FDA Received12/08/2023
Supplement Dates Manufacturer Received01/25/2024
04/11/2024
Supplement Dates FDA Received02/09/2024
05/01/2024
Date Device Manufactured08/11/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age68 YR
Patient SexFemale
-
-